US 9663790
Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
granted A61KA61K48/0058A61K48/0066
Quick answer
US patent 9663790 (Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression) held by The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center expires Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center
- Grant date
- Tue May 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 25 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K48/0058, A61K48/0066, A61P, A61P3/04